RenovoRx Inc. (RNXT)
NASDAQ: RNXT
· Real-Time Price · USD
1.34
-0.04 (-2.90%)
At close: Jun 26, 2025, 3:59 PM
1.33
-1.12%
After-hours: Jun 26, 2025, 06:09 PM EDT
-2.90% (1D)
| Bid | 1.25 |
| Market Cap | 49.19M |
| Revenue (ttm) | 240K |
| Net Income (ttm) | -10.16M |
| EPS (ttm) | -0.41 |
| PE Ratio (ttm) | -3.28 |
| Forward PE | -4.21 |
| Analyst | Strong Buy |
| Ask | 1.41 |
| Volume | 140,817 |
| Avg. Volume (20D) | 160,104 |
| Open | 1.34 |
| Previous Close | 1.38 |
| Day's Range | 1.32 - 1.36 |
| 52-Week Range | 0.75 - 1.69 |
| Beta | 1.32 |
About RNXT
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol RNXT
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for RNXT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
RenovoRx Inc. is scheduled to release its earnings on Aug 12, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
4 months ago
-20.55%
RenovoRx shares are trading lower after the compan...
Unlock content with
Pro Subscription
4 months ago
-2.01%
RenovoRx shares are trading lower after the company announced a proposed public offering.
1 month ago · seekingalpha.com
RenovoRx, Inc. (RNXT) Q1 2025 Earnings Conference Call TranscriptRenovoRx, Inc. (NASDAQ:RNXT ) Q1 2025 Earnings Conference Call May 15, 2025 4:30 PM ET Company Participants Valter Pinto - IR Ramtin Agah - Founder and Chief Medical Officer Shaun Bagai - CEO Ronald K...
2 months ago · businesswire.com
RenovoRx to Present at LD Micro Invitational XV Conference in New York on April 10thMOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a life sciences company developing innovative targeted oncology therapies and commercializing Renov...
